Truist cuts Viking Therapeutics price target to $85
Truist Securities cut its price target on Viking Therapeutics to $85.00 from $87.00, per Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.